NeoTX Therapeutics
About:
NeoTX Therapeutics is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy.
Website: http://predictivetx.com
Top Investors: Maurice R. Greenberg, Tako Ventures, J. Tomilson Hill, NDFOS
Description:
NeoTX is a specialty biopharmaceutical company, with a focus on research and development in oncology immunotherapy. With a strong research and development team, our strategy is to build a patented, proprietary and unique product pipeline to capitalize on technologies that NeoTX is developing independently and through collaborative partnerships and license agreements.
$65M
$1M to $10M
Rehovot, HaMerkaz, Israel
2015-01-01
Asher Nathan, Robert Harow
11-50
2020-02-19
Private
© 2025 bioDAO.ai